DAPK-IN-2
CAS No. 304000-05-3
DAPK-IN-2( —— )
Catalog No. M36987 CAS No. 304000-05-3
DAPK-IN-2 (WAY-380496) is a DAPK inhibitor. DAPK-IN-2 has potential anticancer activity, regulates autophagy and can be used to study cerebral infarction and ischemic diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 141 | Get Quote |
|
| 5MG | 217 | Get Quote |
|
| 10MG | 337 | Get Quote |
|
| 25MG | 544 | Get Quote |
|
| 50MG | 724 | Get Quote |
|
| 100MG | 963 | Get Quote |
|
| 500MG | 1917 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDAPK-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionDAPK-IN-2 (WAY-380496) is a DAPK inhibitor. DAPK-IN-2 has potential anticancer activity, regulates autophagy and can be used to study cerebral infarction and ischemic diseases.
-
DescriptionDAPK-IN-2 is a DAPK inhibitor. DAPK-IN-2 can be used for the research of cerebral infarction and ischemic diseases.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetDAPK
-
RecptorDAPK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number304000-05-3
-
Formula Weight310.3
-
Molecular FormulaC17H14N2O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 2 mg/mL (6.45 mM; Ultrasonic (<60°C)
-
SMILESCOC1=C(OC)C=C(C=C1)C1=N\C(=C\C2=CC=CN=C2)C(=O)O1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Okamoto M, et al. Structure-activity relationship of novel DAPK inhibitors identified by structure-based virtual screening. Bioorg Med Chem. 2010;18(7):2728-2734. ?
molnova catalog
related products
-
DRAK2-IN-16
DRAK2-IN-116 is a potent, selective DRAK2 inhibitor with IC50 of 3 nM.
-
TC-DAPK 6
TC-DAPK 6 is an ATP-competitive inhibitor of Death-associated protein kinase (DAPK) with IC50s of 69 and 225 nM for DAPK1 and DAPK3.
-
HS148
HS148 (DAPK3 inhibitor HS148) is a selective DAPK3 inhibitor with Ki of 119 nM.
Cart
sales@molnova.com